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Although the induction of pigmentation following expo-
sure of melanocytes to ultraviolet light in vivo and in vitro
is well documented, the intracellular mechanisms
involved in this response are not yet fully understood.
Exposure to UV-B radiation leads to the production of
DNA damage, mainly cyclobutane pyrimidine dimers,
and it was recently suggested that the thymidine dinucle-
otide pTpT, mimicking small DNA fragments released
in the course of excision repair mechanisms, could trigger
melanin synthesis. We now report that the thymidine
dinucleotide pTpT induces melanogenesis both in human
normal adult melanocytes and in human melanoma cells.
Thus, the SOS-like response suggested by Gilchrest’s
work to be evolutionary conserved, based primarily on
work in murine cells and guinea pigs, is also apparently
present in the human. Thymidine dinucleotide is non-
Ultraviolet exposure of human skin triggers melaninpigmentation and skin darkening, a response familiarlyknown as tanning. Ultraviolet wavelengths and histo-logic mechanisms involved in melanogenesis andtanning are well documented (Gilchrest et al, 1996).
Cellular and molecular mechanisms of melanogenesis, resulting in the
activation of tyrosinase (the principal rate-limiting enzyme of melanin
synthesis) have been actively investigated (Ferguson and Kidson, 1997).
Ultraviolet irradiation can directly affect epidermal melanocytes, but
ultraviolet-induced melanogenesis also involves other cell types among
which keratinocytes appear to play a major role by secreting paracrine
factors such as bFGF and ET-1 (Halaban et al, 1987; Imokawa et al,
1992). Both direct effects of UV photons on melanocytes and indirect
effects of photons interacting with keratinocytes, fibroblasts, and
conceivably other cells in the skin contribute to the final tanning
response.
Little is known, however, of the molecular mechanisms leading to
tyrosinase activation. Data support a role for photochemical reactions
involving membrane lipids in modulating melanogenesis. Some studies
have implicated the diacylglycerol/protein kinase C pathway (DAG/
PKC) (Gordon and Gilchrest, 1989; Friedman et al, 1990; Punnonen
and Yuspa, 1992) in melanin synthesis: tyrosinase activity is regulated
at least in part by PKC-β mediated phosphorylation of its cytoplasmic
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toxic to melanoma cells and does not induce apoptosis
in these cells, but induces S phase cell cycle arrest and a
proliferation slow down. Because thymidine excess in
culture medium leads to the synchronization of cells in
S phase, we investigated whether this phenomenon was
involved in the increase in melanin synthesis. We show
that melanin synthesis is specifically triggered by the
dimeric form of the thymidine and not by the monomeric
form pT. Thus, our data strongly support that thymidine
dinucleotides pTpT mimic at least part of the effects
of ultraviolet irradiation, and may hence represent an
invaluable model in the study of the molecular events
involved in melanogenesis induction triggered through
DNA damage. Key words: human adult melanocytes/human
melanoma/proliferation/pyrimidine dimers. J Invest Dermatol
111:472–477, 1998
domain (Park et al, 1993a, b). Release of DAG from cell membranes
immediately after ultraviolet irradiation is likely to be a mechanism for
enhanced melanogenesis following UV exposure (Nishizuka, 1992;
Punnonen and Yuspa, 1992).
More recently, UV-induced DNA damage and/or repair have been
linked to melanogenesis. The action spectrum for production of DNA
photoproducts is essentially identical to that for ultraviolet-induced
pigmentation (Parrish et al, 1982; Freeman et al, 1989). The great
majority of UV-B induced DNA photoproducts involve adjacent
pyrimidine moieties, µ80% specifically involve thymidine dinucleotides
(Setlow and Carrier, 1966). In the DNA of ultraviolet-irradiated cells,
these photoproducts are recognized and repaired by nucleotide excision
repair (Tornaletti and Pfeifer, 1996). The repair process leads to the
release of short DNA fragments containing the cyclobutane pyrimidine
dimer or other dipyrimidine photoproducts (Huang et al, 1992; Tateishi
et al, 1993). A prokaryotic endonuclease, T4 endonuclease V, which
enhances rate-limiting incision of thymidine dimers, has been shown to
increase melanogenesis in ultraviolet-irradiated melanocytes, suggesting
that DNA repair directly stimulates the tanning response (Gilchrest
et al, 1993). Indeed, treatment of mouse melanoma cells or guinea pig
skin with small DNA fragments or pyrimidine dinucleotide pTpT
results in increased melanogenesis (Eller et al, 1994, 1996). These
results strengthen the idea of an evolutionary conserved response to
UV irradiation. Indeed, it has long been known that the prokaryote
response to UV, the so-called SOS response, induces a set of more
than 20 genes involved in DNA repair and cell survival (Walker, 1984).
These genes are triggered by a protein (RecA) activated by interaction
of the single stranded DNA generated following UV irradiation
(Phizicky and Robert, 1981). Because melanin is photoprotective in
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human skin against UV radiation, enhanced melanogenesis might be
part of the SOS response in skin.
We now report that the thymidine dinucleotide pTpT induces
melanin synthesis in normal human adult melanocytes and human
melanoma cells. pTpT induces an S phase cell cycle arrest and a
proliferation slow down, but melanin synthesis appears to be inde-
pendent of effects of pTpT on the cell cycle and proliferation rate.
MATERIAL AND METHODS
Cell culture and treatment Dermatomed skin (0.5 mm thick) was floated
on a trypsin solution (0.05%) at 4°C overnight. After separation of the epidermis,
epidermal cells were plated at high density in MCDB153 medium (KBM,
Clonetics, Rockville, MD) supplemented with 0.5 µg hydrocortisone per ml,
5 µg insulin per ml, and 56 µg bovine pituitary extract per ml. After 24 h, the
cells were transferred as previously described (Gilchrest et al, 1984) in M199
medium (Gibco BRL, Walkersville, MD), supplemented with 0.18 mM calcium,
hydrocortisone (0.5 µg per ml), insulin (10 µg per ml), epidermal growth factor
(10 ng per ml), basic fibroblast growth factor (10 ng per ml) (Halaban et al,
1987), and phorbol 12,13 dibutyrate (0.5 mM) without fetal calf serum. The
following week, the cells were transferred in calcium depleted M199 medium
with 5% calcium free fetal calf serum. One week before and during the
experiment the phorbol 12,13 dibutyrate was removed from the medium.
A375P human melanoma cells were purchased from the American Type
Culture Collection. M4Be human melanoma cells were previously established
in the laboratory (Jacubovich et al, 1985). Melanoma cells were grown in
Dulbecco’s modified Eagle’s medium or McCoy 5a supplemented with 10%
fetal calf serum, 200 units penicillin per ml, and 20 µg streptomycin per ml at
37°C in an humidified 5%CO2 incubator. 70% confluent cell cultures were
used for treatment with nucleotides. Briefly, cells were provided with fresh
medium containing 30–50 or 100 µM pTpT (Sigma, St Louis, MO) or 100–
500 µM pT (Sigma) or with fresh control medium, and were continually
exposed to the nucleotide for the duration of the experiment.
Melanin assay Cells were trypsinized, washed twice with phosphate-buffered
saline solution, and solubilized in 1 ml 1N KOH with vigorous vortexing for
10 min after heating for 30 min at 60°C. Melanin concentration was determined
by measurement of OD405 and comparison with a standard curve obtained
using a synthetic melanin (Sigma).
14C-DOPA uptake Cells were incubated with the melanin precursor L-3,4
dihydroxyphenyl [1–14C]alanine (14C-DOPA) for 72 h. Cells were rinsed twice
with phosphate-buffered saline, trypsinized, centrifuged, and extracted twice
with 2 ml 5% trichloroacetic acid in 95% ethanol at 4°C. The incorporated
radioactivity was determined using a scintillation counter.
Cell cycle analysis Cells were trypsinized, washed twice with phosphate-
buffered saline, and fixed in 70% ethanol for 30 min at 4°C. The cells were
treated with 1 U DNase-free RNase (Sigma) in 1 ml phosphate-buffered saline
for 30 min at 37°C. The DNA content was detected by propidium iodide
(0.05 mg per ml). The stained cells were analyzed by Facscalibur (Becton
Dickinson, San Jose, CA) in the CellQuest program. Fluorescence events due
to debris were substracted before analysis.
Cellular proliferation assay Cellular proliferation was measured using the
Alamar Blue dye assay (Ahmed et al, 1994). Alamar Blue, devoid of any effect
on cell viability and cellular proliferation, contains a Redox indicator. Cellular
proliferation induces chemical reduction and a change in color from blue to
red. The intensity of red color, which can be accurately measured by a
fluorimetric assay, reflects the extent of cellular proliferation. Briefly, cells were
suspended to a final concentration of 2500 cells per ml and 1 ml cell suspension
was dispensed in each well of a 24 well culture plate. To the cultured cells,
100 µl Alamar Blue (10% of incubation volume) was added according to the
manufacturer’s instructions (Alamar, Sacramento, CA). The cells were incubated
for 4 h with the Alamar Blue without washing and the fluorescence was read
on a plate reader (Cytofluor, Biosystem, Framingham, MA) without extraction.
All assays were performed in triplicate, standard deviations were calculated and
never exceeded 5%. Population doubling times were determined graphically
from a semilogarithmic linear plot of cell growth.
RESULTS
Pyrimidine dinucleotides induce melanogenesis in human nor-
mal adult melanocytes and melanoma cells Pyrimidine dinucleo-
tides were shown to enhance melanogenesis in murine melanoma cells
and in human newborn foreskin melanocytes cultured in vitro as well
as in guinea pig skin (Eller et al, 1994). To further examine the effect
Table I. Melanogenesis induced in human melanocytes
by pTpT
Melanina 14C-DOPA incorporationb
Control pTpTc Control pTpTc
Normal adult 14.6 6 2.6d 23.7 6 4.3 16009 6 206 30866 6 4358
human
melanocytes
M4Be 10.7 6 1.1 15.2 6 2.4 945 6 49 1324 6 54
aµg melanin per 106 cells.
bcpm per 106 cells.
c50 µM.
dFigures represent means of three independent determinations.
Table II. Melanogenesis induced in M4Be human melanoma
cells by pTpT
Liposomesa Control pTpTb
– 11.6 6 1.0c 28.4 6 1.8
1 47.0 6 4.2 120.4 6 3.9
aLiposomes were prepared by dispersing 1% (wt/vol) phospholipids with or without
0.21% pTpT in distilled water as described previously (Redziniak and Meybeck, 1986).
Soybean phospholipids (Alcolec F100) were obtained from the American Lecithin Company
(Bethesda, MD). Liposomes thus prepared have a mean size of 100 nm.
b100 µM.
cµg melanin per 106 cells. Figures represent means of three independent determinations.
Table III. Cell cycle distribution of M4Be melanoma cells
following 24 h treatment with pTpT
Control pTpT
G1 64.7 6 1.2 ‡ 50.1 6 0.3
S 26.3 6 1.0 43.8 6 0.3
G2 8.9 6 0.3 6.1 6 0.3
a50 µM.
bPercentage of cells.
of pyrimidine dinucleotides on pigmentation of human melanocytes,
primary cultures of normal human adult melanocytes and the human
melanoma cell line M4Be were continuously exposed to 50 µM pTpT
for 7 d. Measurement of the melanin content shows that this treatment
resulted in a significant increase in pigmentation of both normal
melanocytes and melanoma cells. Comparable results were obtained
when pigment formation was measured through incorporation of a
melanin precursor, 14C-DOPA, thus showing that pigment formation
in dinucleotide-treated human melanocytes results from de novo pigment
synthesis (Table I).
In an attempt to increase penetration of dinucleotides through cell
membranes, which may eventually limit their effect, human melanoma
cells were exposed continuously for 7 d to 100 µM pTpT in liposomes
incorporated in the culture medium. Surprisingly, control empty
liposomes appeared to increase the melanin content of M4Be melanoma
cells; however, the results of these experiments consistently show that
exposure of human melanoma cells to pTpT results in a 2.5-fold
increase in their melanin content, irrespective of the presentation of
the dinucleotides, in solution or incorporated into liposomes (Table II).
Thus, at concentrations of 50–100 µM, pyrimidine dinucleotide
pTpT significantly enhances melanogenesis, by a factor ranging from
1.5 to 2.5 according to experimental conditions and target cells, in
normal adult melanocytes as well as in human melanoma cells.
Pyrimidine dinucleotides induce cell cycle arrest and prolifera-
tion delay in human melanocytes To further analyze the effect
of pTpT on human melanocytes, we studied cell cycle and proliferation
of these cells. Studies with human adult melanocytes were rendered
uninterpretable by their low proliferation rate and long doubling time
under basal conditions, so cell cycle studies were performed with
human melanoma cells.
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Figure 1. S phase arrest of A375P cells following treatment with pTpT.
Cells continuously exposed to pTpT (50 µM) were stained for DNA content
with 0.05 mg propidium iodide per ml at selected times. Ordonate, number of
cells; FL-2H, fluorescence intensity of propidium iodide. (a) Control; (b) 24 h;
(c) 48 h.
M4Be melanoma cells continuously exposed for 24 h to 50 µM
pTpT showed an increase in the proportion of cells in S phase:
43.8% 6 0.3 as compared with 26.3% 6 1.0 in control untreated cells
(Table III). The increase in the proportion of cells in S phase was still
demonstrable after 72 h treatment (data not shown); however, because
M4Be cells are slow growing with a doubling time exceeding 30 h,
similar experiments were performed using the A375P human melanoma
cell line. Under the same conditions, A375P melanoma cells continu-
ously exposed to 50 µM pTpT showed a transient accumulation in
the S phase after 24 h of treatment. Later, and though pyrimidine
dinucleotides were still present in the culture medium, cells appeared
to resume cycling at 48 h (Fig 1). Attempts to further characterize the
cell population gathered in the S phase using bromodeoxyuridine
labeling were unsuccessful, probably due to a competition between
bromodeoxyuridine and thymidine dinucleotides in the culture
medium.
Figure 2. Growth inhibition of A375P cells by pTpT (50 mM). Cells were
plated in 24 well plate at a density of 2500 cells per well. Alamar blue was
added in medium 24, 48, 72, and 96 h after beginning of treatment and
fluorescence was read 4 h later.
Cell proliferation analysis demonstrates that pTpT slows proliferation
rate: the doubling time of pTpT-treated A375P cells being 32 h,
compared with a doubling time of 25 h in control cells, corresponding
to a growth inhibition of 35% in a 96 h experiment (Fig 2).
Removal of the pyrimidine dinucleotides from the culture medium is
accompanied by restoration of their proliferation capacity (data not
shown). It should be noted that pTpT concentrations up to 100 µM
have no demonstrable cytotoxic effect on human melanoma cells, as
evidenced from the raw data scattergrams of pTpT-treated A375P cells
shown in Fig 3. Similarly, consideration of Fig 1 shows that there is
no sub-G1 peak of apoptotic cells in pTpT-treated A375P cells. Hence,
the slow down in proliferation rate is unlikely to result from a cytotoxic
effect or from increased apoptosis.
Cell cycle arrest and proliferation slow down are not directly
involved in thymidine dinucleotide-induced melano-
genesis High concentrations of thymidine prevent cell division, and
removal of excess thymidine yields a wave of cell synchrony. Double
thymidine block at concentrations of 1–2 mM is widely used to
synchronize cells in the S phase (Bootsma et al, 1964). Therefore, it
can be questioned whether the S phase arrest observed following
exposure to 50–100 µM pTpT of melanoma cells results from a
potentialization of the thymidine block due to the dimeric form of
thymidine, and whether the induction of melanogenesis results from
the effects of thymidine dinucleotide on cell cycle and proliferation rate.
Experiments using thymidine monophosphate (pT) at different
concentrations showed that at a concentration of 100 µM, correspond-
ing to a thymidine amount comparable with that of 50 µM pTpT, no
cell cycle effect was observed (Fig 4a); however, increasing pT
concentration up to 300 µM resulted in an S phase arrest similar to
that observed after 50 µM pTpT treatment of A375P melanoma cells
(Fig 4b). Similarly, thymidine monophosphate displayed only a mild
effect onto cell proliferation rate at a concentration of 100 µM (Fig 5a),
and an effect comparable with that of 50 µM pTpT, at a concentration
of 300 µM, the doubling time of 300 µM pT-treated A375P melanoma
cells being 33 h compared with a doubling time of 25 h in untreated
control cells (Fig 5b).
Despite the fact that comparable effects on cell cycle and cell
proliferation of human melanoma cells are obtained with concentrations
of 300 µM pT and 50 µM pTpT, melanogenesis could only be induced
in melanoma cells following treatment with the dinucleotide pTpT,
and even a nontoxic 500 µM pT concentration was unable to trigger
melanogenesis in M4Be cells (Table IV), suggesting that the effect on
melanin synthesis is specific of the dimeric form of phosphothymidine.
DISCUSSION
The exposure of human melanocytes to thymidine dinucleotide pTpT
results in an enhancement of melanogenesis. Our results thus confirm
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Figure 3. Absence of cytotoxicity of pTpT for A375P cells. Raw data
scattergrams of (a) control and (b) pTpT-treated A375P cells. Cells were exposed
to 50 µM pTpT for 24 h and their size and internal structure were analyzed
by flow cytometry. FSC-H, forward scatter; SSC-H, side scatter. Red dots
represent cell population selected for further analysis, whereas black dots denote
either cell doublets (upper right) or cell debris (lower left). pTpT-treated cells
show a slight increase in cell volume, compatible with accumulation of cell in
S/G2 phases.
and extend the original observation of Eller et al (1994), who reported
that exposure of mouse melanoma cells S91 and guinea pig skin to
pTpT resulted in an increase in melanin synthesis, and that this effect
was specific of the thymidine dinucleotide because no such effect
was observed following treatment of the melanocytes with similar
concentrations of the purine dinucleotide pdApdA. Our experiments,
using primary cultures or early passages of normal human adult
melanocytes, slowly growing but fully able to trigger a melanogenic
response to ultraviolet B irradiation, show that a 100 µM concentration
of the dinucleotide pTpT enhances melanogenesis by a factor of 2.5
and that a lower concentration (30–50 µM) still yields a significant
response. Our experiments further suggest that the induction of a
melanogenic response is dependent on the dimeric form of thymidine,
as no significant melanin synthesis was obtained following treatment
of melanoma cells with the monomeric form of phosphothymidine
(pT) at concentrations as high as 500 µM. The increase in melanin
content of M4Be human melanoma cells following treatment with
empty liposomes is likely to result from surface membrane events.
Further studies will be needed to elucidate whether there is activation
Figure 4. Cell cycle changes in A375P cells following exposure to pT.
Cells were exposed to 100 µM (a) or 300 µM (b) pT and stained for DNA
content with 0.05 mg propidium iodide per ml at selected times. Ordinate,
number of cells; FL-2H, fluorescence intensity of propidium iodide.
of specific transmembrane receptors in the diacylglycerol/protein kinase
C pathway, the PKA pathways, or other signaling molecules involved in
melanogenesis. This could be an nice model for study of melanogenesis;
however, it should be stressed that these events are certainly different
from those triggered by the thymidine dinucleotide pTpT, because
there is an additive interaction between the effects of thymidine
dinucleotide and of liposomes in melanogenesis enhancement: as a
matter of fact, treatment of M4Be cells with pTpT enhances melanin
content by a factor of 2.5, whereas treatment with empty liposomes
enhances melanin content by a factor of 4 and treatment of the same
cells by pTpT in liposomes enhances melanin content by a factor of 10.
The most striking observation of the experiments reported here is
that following exposure to thymidine dinucleotide, human melanocytes
accumulate in the S phase of the cell cycle. It is highly unlikely that
the increase in S phase cells might be interpreted as stemming from a
larger number of actively cycling cells, because human melanoma cell
lines are usually characterized by a large growth fraction, and because
an increase in the proportion of cycling cells should have resulted in
an increase in proliferation rate or apoptosis. A double block by a
thymidine excess has long been used to synchronize cells, and it has
long been known that such a synchronization results from a diminution
of the progression of cells through the S phase of the cell cycle (Galvazi
and Bootsma, 1966; Galvazi et al, 1966). The concentrations of
thymidine required to achieve cell synchronization, however, were
usually 20–50 times higher (Rosenfeld et al, 1973) than the concentra-
tions of thymidine dinucleotide used in the experiments reported here
that resulted in S phase accumulation of treated melanoma cells. Indeed,
exposure of the melanoma cells to comparable amounts of thymidine
mononucleotide (100 µM) failed to result in significant cell cycle
changes, although further increasing thymidine mononucleotide con-
centration up to 300 µM resulted in S phase arrest. Thymidine
dinucleotide might interfere with DNA synthesis, but it is unlikely
that the significant accumulation of melanoma cells in the S phase of
the cell cycle that we evidenced following treatment with thymidine
dinucleotide would simply result from exposure to thymidine, and
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Figure 5. Effect of pT on the growth of A375P cells. Cells were exposed
to 100 µM (a) or 300 µM (b) pT and cell growth was monitored using the
Alamar Blue method (see legend to Fig 2).
Table IV. Effect of pTpT and pT on pigmentation of human
melanoma cells
Melanina
Control 19.6 6 1.48
pTpTb 42.2 6 0.56
pTc 26.7 6 1.76
pTd 24.5 6 1.6
aµg melanin per 106 cells.
b50 µM.
c300 µM.
d500 µM.
further investigations are needed to eventually document the mechanism
by which the dimeric form of thymidine causes cell cycle arrest. It is
worthy to note that another pyrimidine analog, bromodeoxyuridine,
which induces growth arrest, melanogenesis inhibition (Kreider et al,
1974; Silagi, 1976), and a decrease in tumorigenicity of human
melanoma cells (Rieber et al, 1989; Valyi-Nagy et al, 1993), at a
concentration of 2.5 µg per ml (8 µM), is able to control human
melanoma cell growth, probably by acting at a point in G1 beyond
cyclin D synthesis in which it prevents S phase transition of human
melanoma cells by influencing the levels of expression of the p21
inhibitor and decreasing the cyclin A activator of cdk2 (Rieber et al,
1996). Most recently, Eller et al (1997) have described growth retard-
ation and p21 induction by pTpT. The elucidation of the point in the
cell cycle where thymidine dinucleotide pTpT acts will require further
investigation of the expression of cyclins, more especially cyclin A and
cyclin D, and cdk2 in treated human melanoma cells. Friedmann and
Gilchrest (1987) have shown years ago that human melanocytes exposed
daily to physiologic ranges of ultraviolet radiation show a dose-related
increase in melanin content per cell and uptake of melanin precursors,
accompanied by growth inhibition. From our experiments, however,
it is clear that cell cycle arrest and growth inhibition do not by
themselves result in melanogenesis enhancement.
Tanning is a complex protective response of skin triggered by
ultraviolet radiation to prevent further ultraviolet radiation-induced
damage. A central element of such a protective response is the
ultraviolet-triggered induction of melanin synthesis. It is becoming
increasingly evident that at least two different signaling pathways could
actually be involved in the induction of melanogenesis. One major
and well-investigated pathway involves biochemical mediators such as
α-melanotropin and ACTH synthesized in skin by epidermal melano-
cytes and keratinocytes. Thus, Im et al (1998) have recently published
some evidence of an α-melanotropin mediated protective effect in
human melanocytes following ultraviolet B irradiation. In addition to
this well-established pathway, it is becoming more and more evident
that DNA damage, resulting from ultraviolet exposure but also from
exposure to other DNA damaging agents, enhances melanogenesis
(Eller et al, 1996). Recent work by Gilchrest’s group suggests the
existence of an SOS-like response in eukaryotic cells similar to the
one occurring in prokaryotic cells in response to ultraviolet-induced
DNA damage. Indeed, it is well established that in prokaryotic cells,
in response to DNA damage or when DNA replication is inhibited,
an intracellular signal for SOS induction is generated. Evidence suggests
that this signal consists of regions of single-stranded DNA that are
generated when the cell attempts to replicate a damaged template or
when its normal process of DNA replication is interrupted (Sassanfar
et al. 1990). The S phase arrest evidenced in our experiments may be
explained by this SOS induction. It is likely that pTpT, and perhaps
other small nucleic acids, mimics the products of DNA damage or
processed DNA-damage intermediates, which may explain why pTpT,
which is not the cyclobutane pyrimidine dimer formed following
ultraviolet irradiation, is actually inducing melanogenesis. Thus, the
SOS-like response suggested by Gilchrest’s work to be evolutionary
conserved, based primarily on work in murine cells and guinea pigs,
is also apparently present in the human.
Several studies have previously shown that melanogenesis is related
to DNA repair (Gilchrest et al, 1993), and, most recently, it was
demonstrated that pTpT enhances DNA repair in human skin cells
(Eller et al, 1997). Xeroderma pigmentosum (XP) patients, however,
who are deficient in DNA repair mechanisms, are able to tan after
exposure to ultraviolet, most likely through activation of the major
melanogenesis pathway involving biochemical mediators. Hence, it
would be of utmost interest to explore the ability of melanocytes from
XP patients to trigger melanogenesis when exposed to pTpT, this
would help to elucidate whether there is an association between DNA
repair and increased melanogenesis, both phenomena triggered by
thymidine dinucleotides.
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